358 related articles for article (PubMed ID: 19638274)
1. The effects of exosite occupancy on the substrate specificity of thrombin.
Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
[TBL] [Abstract][Full Text] [Related]
2. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
[TBL] [Abstract][Full Text] [Related]
3. Energetics of thrombin-thrombomodulin interaction.
Vindigni A; White CE; Komives EA; Di Cera E
Biochemistry; 1997 Jun; 36(22):6674-81. PubMed ID: 9184147
[TBL] [Abstract][Full Text] [Related]
4. Thrombin specificity.
Guillin MC; Bezeaud A; Bouton MC; Jandrot-Perrus M
Thromb Haemost; 1995 Jul; 74(1):129-33. PubMed ID: 8578445
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to thrombin directed against both of its cryptic exosites.
Mollica L; Preston RJ; Chion AC; Lees SJ; Collins P; Lewis S; Lane DA
Br J Haematol; 2006 Feb; 132(4):487-93. PubMed ID: 16412021
[TBL] [Abstract][Full Text] [Related]
6. Exosite 2-Directed Ligands Attenuate Protein C Activation by the Thrombin-Thrombomodulin Complex.
Chen K; Stafford AR; Wu C; Yeh CH; Kim PY; Fredenburgh JC; Weitz JI
Biochemistry; 2017 Jun; 56(24):3119-3128. PubMed ID: 28549218
[TBL] [Abstract][Full Text] [Related]
7. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity.
Ye J; Liu LW; Esmon CT; Johnson AE
J Biol Chem; 1992 Jun; 267(16):11023-8. PubMed ID: 1317850
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.
Fuentes-Prior P; Iwanaga Y; Huber R; Pagila R; Rumennik G; Seto M; Morser J; Light DR; Bode W
Nature; 2000 Mar; 404(6777):518-25. PubMed ID: 10761923
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fluid phase and clot-bound thrombin by the thrombin exosite I ligand LU 58463: comparison with heparin and hirudin.
Filippucci E; Agnelli G; Leone M; Nenci GG
Haematologica; 2002 Oct; 87(10):1116-7. PubMed ID: 12368171
[No Abstract] [Full Text] [Related]
10. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
11. Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.
Verhamme IM; Olson ST; Tollefsen DM; Bock PE
J Biol Chem; 2002 Mar; 277(9):6788-98. PubMed ID: 11724802
[TBL] [Abstract][Full Text] [Related]
12. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
[TBL] [Abstract][Full Text] [Related]
13. Identification of the substrate-binding exosites of two snake venom serine proteinases: molecular basis for the partition of two essential functions of thrombin.
Maroun RC; Serrano SM
J Mol Recognit; 2004; 17(1):51-61. PubMed ID: 14872537
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
[TBL] [Abstract][Full Text] [Related]
15. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
Rezaie AR
Biochemistry; 1999 Nov; 38(44):14592-9. PubMed ID: 10545182
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes.
Tasset DM; Kubik MF; Steiner W
J Mol Biol; 1997 Oct; 272(5):688-98. PubMed ID: 9368651
[TBL] [Abstract][Full Text] [Related]
17. Rational design and selection of bivalent peptide ligands of thrombin incorporating P4-P1 tetrapeptide sequences: from good substrates to potent inhibitors.
Su Z; Vinogradova A; Koutychenko A; Tolkatchev D; Ni F
Protein Eng Des Sel; 2004 Aug; 17(8):647-57. PubMed ID: 15358856
[TBL] [Abstract][Full Text] [Related]
18. Identification of protease exosite-interacting peptides that enhance substrate cleavage kinetics.
Jabaiah AM; Getz JA; Witkowski WA; Hardy JA; Daugherty PS
Biol Chem; 2012 Sep; 393(9):933-41. PubMed ID: 22944693
[TBL] [Abstract][Full Text] [Related]
19. Exosites determine macromolecular substrate recognition by prothrombinase.
Krishnaswamy S; Betz A
Biochemistry; 1997 Oct; 36(40):12080-6. PubMed ID: 9315846
[TBL] [Abstract][Full Text] [Related]
20. Occupancy of anion binding exosite 2 on thrombin determines Ca2+ dependence of protein C activation.
Liu LW; Rezaie AR; Carson CW; Esmon NL; Esmon CT
J Biol Chem; 1994 Apr; 269(16):11807-12. PubMed ID: 8163479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]